SEC Filing Summary: Bellevue Life Sciences Acquisition Corp.
Business Context and Reporting Period
This Form 8-K was filed by Bellevue Life Sciences Acquisition Corp. (BLAC) on September 16, 2024, reporting an event that occurred on September 10, 2024. The registrant is a Special Purpose Acquisition Company (SPAC) listed on The Nasdaq Stock Market LLC. The filing addresses an extension of the deadline to consummate a business combination.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. The only specific financial figure disclosed is a deposit of $50,000 made into the company's trust account on September 10, 2024.
Material Changes
The primary material change reported is the extension of the date by which the Company must complete a business combination. This extension was facilitated by the $50,000 deposit into the trust account.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the implication that the company required additional time to finalize a merger. The document does not detail the terms of the extension or the status of any potential target companies.
Investor Verification Checklist
- Verify the new deadline date for consummating a business combination, as it is not explicitly stated in this summary text.
- Confirm the total balance of the trust account following the $50,000 deposit.
- Review the terms of the extension agreement to understand any associated fees or dilution impacts.
- Check for subsequent filings regarding the status of the business combination search.